Drug Designing in Discovery Studio

 

Bhagyashree L. Jejurikar*, Sachin H. Rohane

Department of Pharmacy, Yashoda Technical Campus, Satara 415015 India.

*Corresponding Author E-mail: bljejurikar@gmail.com

 

ABSTRACT:

The process of drug development and drug discovery is very challenging expensive and time consuming. It has been accelerated due to devlopment of computational tools and methods. In current situation lots of molecular docking software are available in the market, during lirerature survey it was found that Discovery Studio is suit of software for stimulating small molecule and macromolecule system. It is developed and distributed by Accelarys. It helps to Investigate and test hypothesis in silico prior it costly experimental implimentation thus reducing the time and expense involved in bringing products to market. it is developed and distributed by Dassault system BIOVIA (formerly Accelerys). During literature survey it was found that Discovery Studio software was efficiently guided to as author regarding mainly biological activities like anti-inflammatory activity, anti-tubercular activity, anti-bacterial activity, anti-viral activity, anti-diabetic activity and anti-oxidant activity.

 

KEYWORDS: Molecular docking, Drug discovery, Discovery studio.

 

 


INTRODUCTION:

Molecular docking is one of the most frequently used methods in structure based drug design, due to its ability to predict the binding- confirmation of the small molecule ligands to the appropriate target binding site. Discovery and development of a new drug is generally known as a very complex process which takes a lots of time and resources. So now a days computer aided drug design are used very widely to increase the efficiency of the discovery and development courses. CADD are evaluated as promising technique according to they need, in between all these structure – based drug design and ligand – based drug design. As very efficient and powerful technique in the drug Discovery and development. These both methods can be applied with molecular docking to the virtual screening for lead identification and optimization. Molecular docking is a key tool in structural molecular biology and computer assisted drug design.

 

Discovery studiosoftware is suit for stimulating small molecule and Macromolecule system. The product suite as astrong academic collaboration programme, supporting scientific research and makes use of a number of software algorithms developed originally in the scientific community, including CHARMM, MODELLER, DELPHI, ZDOCK, DMol3 and more [1-3].

 

REVIEW OF LITERATURE:

Qinggang Meng and et al used Discovery Studio Software check the Rizoma Atractylodis and Rhizoma Atractylodis Macroephalae herbal pairs against type 2 diabetes mellitus. the interaction between targets and ligands were observed and analayzed, according to CDocker interaction energy, most compounds from the herbal pair had good binding activities with receptor and nine compounds had even higher scores than those of the original ligands [4].

 

Shola Elijah Adeniji and et al used Discovery Studio stimulated Software to check the Anti tubercular modeling, molecular docking stimulation and insight toward computational design of novel compounds as potent antagonist against DNA gyrase receptor. Tuberculosis continue to be critical health problem causing death and illness among millions of people yearly and ranked the second leading cause of mortality among the communicable infections in the world. This work accessed the application of modelling technique to predict the inhibitory activity of some prominent compounds which been reported to efficient against mycobacterial tuberculosis [5].

 

Sabir Ali and et al used Discovery Studio4.0 accelrys Software to check anti bacteriak, anticancer, and molecular docking studies of macrocyclic metal complexes of dihydrazide and diketone. this studies suggest an octahedral geometry for all complexes, compounds found active against B, Substillis and S,aureusand P, aeruginosa and E.coil bacteria, Zn (II) complex showed significant anticancer activity against squamous cell carcinoma cell tested by MTT assay method. Molecular docking studies with EGFR tyrosine kinase were also carried out . all these results show that some of synthesized compound have remarkable antibacterial and anticancer property [6].

 

 Mehmet Gokhan Caglayan and et al used Discovery Studio Software to check the Electrochemical ,Spectroscopic and molecular docking studies of the insteraction between the anti –retroviral Indinavir andds DNA in this study electrochemical and DNA biosensor was developed using a straightforward methodology to investigate the ineraction of indinavir with calf thymus double –stranded deoxyribonucleic acid for the first time. The obtained results can offers insights into the inhibitory activity of indinavir, which could heip to broaden its application, thus indinavir can be used to inhibit other mechanisum and /or hallmarks of viral diseases [7].

 

Dominic Agyei and et al used discovery studio software 2019 to study physicochemical characterization and drud likeness evaluation of hypotensive peptides encrypted in flaxseed proteome.in this study, hypotensive peptides derived from mature flaxseed protein sequences were predicted in silico using BIOPEP-UWM with nine protease, three each form digestive, plant and microbial sources. In silico prediction of adsorption, digestion, metabolism, excetion and toxicity (ADME/Tox) profile based on physiochemical properties and Lipinski’s rule of five showed that the peptides were non toxic and had desirsble drug like properties [8].

 

Shola Eljiah Adenjiand et al used Discovery Studio stimulated Software to check Quantum modeling molecular and evaluation of some selected quiniline derivative as antitubercular agents: discovery studio visualize software. Ligand - receptor interaction between quinoilne derivatives and the receptor (DNA gyrase). Docking study indicates that compounds 10 of the derivative with promising biological activity have the ulmost binging anti- tubercular drugs with more efficient activities [9].

 

Nasser Abdulatif Al- Shabib and et al used Discovery studio 4.0 software to investigate the effect of food additive dye “tartrazine“ on BLG fibrillation under invitro condition. Molecular docking results ascertained that Tz binds at the hydrophobic cavityand interact with the key amino acid residues involved in the interaction with different ligands, the spectroscopic,microscopic and computational results electrostatic as well as hydrophobic interaction played a very important role in Tz–induced BLG fibrillation under invitro condition [10].

 

Jian Wang and et al used Discovery Studio Software to study Graphene/Feso4 namocomposite for effective removal of ten triazole fungicides from water solution . Tebucanazole as an example for investigation of the adsorption mechanism by experimental and molecular doking study. The study on adsorption kinetics and thermodynamics were done by taking tebuconazole as an example. Grapheme/Fe3SO4 was prepared and utilized as a adsorbent for removal of ten commonly used triazole fungicides in agriculture [11].

 

Deepu Mathew and et al used Discovery Studio V4.0 Software to check therapeutic molecule for multiple human diseases identified from pigeon pea ( Cajanus Cajan L. Millsp) through GC- MS and molecular docking molecular mechanism behind the therapeutic potential of pigeon pea over the human disease such as rheumatoid arthritis, breast cancer, type II diabetes , malaria, measlesand sickle cell disease were revealed through GC-MS identified phyto – compound ligands with candidate protein [12].

 

Asif Husain and et al used Discovery Studio Software (version4.0,Accelryssoftware) check the molecular docking with COXI and II enzyme, ADMET screening and in vivo anti– inflammatory activity of oxadiazole, thiadiazole and triazole analogus of felbinae. Based on the core structure of felbinac drug, three series (4a-d,5a-d, 6a-n) of five membered heterocylic derivatives containing three heteroatoms were designed and synthesized starting from felbinac. The prepared molecules were the investigated for their anti- inflammatory, ulcerogenicity, and analgesic in experimental animal [13].

 

Maryam A. Jordaan and et al using Discovery Studio visualizer Software to check virtual screening and DFT calculation of FDA approved compounds similar to the non – nucleoside reverse transciptase inhibitor (NNRTI) efavirenz .the compounds were subjected to screening by analyzing their drug likness, such as Lipinski’s rule of five and ADME properties. Study showed that lovastatin and simvastatin might be considered as lead compounds for further development for COVID -19 main perotease inhibitor [14].

 

Assia Belhassan and et al used Discovery Studio2016 Software to study novel triazolo- benzodiazepine analogues as antidepressant targeting by molecular docking and ADMET properties prediction. Docking studies suggested that eleven ligands interacted within activesiteof Drosophila melangaster dopamine transporter (Ddat)) (PDBED:4M48) [most ligands formeH-bond with amino acid phe43, Asp46, Asp475, Tyr123, Ser421 and Gln also exhibited Pi and Pi-Pi. In silico ADME evaluation of compounds shoed more than 96% intestinak absortion for all compound [15].

 

Mohommad k.Parvez and et al used discovery studio software to check plant derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study. Docking of lamivudine indicatedstrong interaction with the modeled HBV pol active site residues that formed stable complex, similarly all the docked antiviral compounds formed very stable complexes with anti-HBV pol. Taken together,our data suggest the anti-HBV potential of thetested natural compounds as novel viral pol RT inhibitors [16].

 

Hanine Hadni and et al used to discovery studio software to check molecular docking andthe antimalarial activity of hybrids 4-anilino-qinoline-triazines derivatives with thewild-type and mutant receptors ofof-DHFR docking studies were performed for previously reported 4-aniloquinoline and 1,3,5-triazines based molecular hybrids. The docking result revealed that these molecular specifically with SER108 and 1LE164 in the pf-DHER binding pocket as that of best active compounds but also showed additional interactions with LEU40 and GLY44 [17].

 

Aliyu Wappah Mahmud and et al used discovery studio software check QSAR and molecular docking studies of 1,3,dioxoisoindoline-4-aminoquinoline as potent antiplasmodium hybrid compounds. The docking result indicates strong binding between 1,3-dioxosoindoline-4-aminoquinoline and plasmodium falciparum lactate dehydrogenase (PFLDH) ,and revealed the important of the morpholinyl substituent and amide linkerin inhibiting PFLDH. These results could serve as a model for designing novel 1,3-dioxoisoindoline-4-aminoquinolines as inhibitors of PFLDH with higher antiplasmodial activities [18].

 

K.Jayasheela and et al used discovery studio to check the conformational and spectroscopic characterization, charge analysis and molecular docking profiles of chromone-3-caboxylic acid using a quantum hybrid computational method. The spectroscopic profile of chromone-3-carboxylic acid (abbreviated as 3CA) was exmined using FT-IR, FT-roman,UV,1H and 13C NMR technique. Result of the docking study identified the sugar phosphate inhibitor activity of the target molecular (C3CA) [19].

 

Mariana Spetea and et al used discovery studio (version3.0) software to check structure activity relationship. Explorations of 14-oxygenated N-Methylmorphonan-6-ones as potent μ-Dpioid receptors against. The crucial role of relative orientation of the ligand in the u or binding site, influencing the property of critical non-covalent interaction that are required to facilitate ligand/-μ or activation by the 14-oxygenated N-methylmorphinan-6-ones,which should be useful for guiding drug design.

 

Shola Elijiah Adeniji and et al using Discovery Studio Visualizer software. To check the theoretical modeling and molecular docking stimulation for investigating and evaluatiny some active compounds as potent anti tubercular agents against MTB CYP 121 receptor. Docking studies revealed the best molecule with docking scores of–13.7 kcal/mol which formed H- bond and hydrophobic interaction with amino acid residue M. Tuberculosis cytochromes ( MTB CYP 121) [20].

 

Shola Elijiah Adeniji and et al used Discovery Studio Visualizer software check the In silico study for evaluating the binding mode and interaction of 1,2,4- triazole and it’s derivatives as potent inhibitors against Lipoate protein B ( Lip B) research has shown that the binding affinity of these compounds wery found to be better than the recommended anti–mycobacterium drugs; isoniazid (-14.6kcal/mol) and ethambutol (- 5.8kcal/ mol). This study provide valuable approach for designing and synthesizing more potent anti–mycobacterium tuerculosis derivatives [21].

 

Ana- Maria Udrea and et al used Discovery Studio Visualizer software to check Laser irradiated phenothiazines: New potential treatment for COVID - 19 explored by molecular docking . In this study predict , using molecular docking, the binding affinity to 15 phenothiazines (antihistaminic and antipsychotic drugs) when interacting with the main protease SARS - coV-2 . Results reveal that thioridazine –and its identified photo products ( mesoridazine and sulforidazine) have high biological activity on the virus main protease [22].

 

CONCLUSION:

This review totally focused on the drug designing in Discovery Studio software and it’s different versions such as Discovery Studio V 4.0, Discovery Studio 2016, Discovery Studio 4.0 Accelrys. This software also useful to check the various biological activities and therapeutic activities such as Anti -inflammatory, Anti- tubercular, Anti-diabetic and Anti- oxidant activity etc.

 

After literature review it was seen that number of researchers suggest Discovery studio software for protein – ligand interaction and the interaction between target and ligands were observed and analyzed.

 

REFERENCE:

1.     Rohane S.H., Makwana A.G., 2017. A Review on Hydrazone, the fascinating field of investigation in medicinal chemistry. Asian J. Res. Chem. 10, 417-430.

2.     Rohane S.H., Makwana A.G., 2019. In silico study for the prediction of multiple pharmacological activities of novel hydrazone derivatives. Ind J. Chem. Sec-B. 58, 387-402.

3.     Rohane S.H., Makwana A.G., 2020. Synthesis and in vitro antimycobacterial potential of novel hydrazones of eugenol. Arab J. Chem. 13, 4495–4504.

4.     Qinggang Meng, Che Che, Shen Zhou, Journal of Traditional Chinese Medical Science (2018) 5, 185- 198.

5.     Shola Elijah Adeniji Olajumoke Bosede Adalumo, Faith Omeyi Ekoja, Medicine in Microecology 5 (2020) 100020.

6.     Sabir Ali, Vandna Singh, Preeti Jain, Vishwas Tripathi, Journal of Sauli Chemical Society (2019) 23, 52- 60.

7.     Sibel A. Ozkan, Fariba Mollarasouli, Burcu Dogan- Topal, Mehmet Gokhan Caglayan, Tugba Taskin–Tok, Journal of Pharmaceutical Analysis 10 (2020) 473- 481.

8.     Dominic Agyeil, Dawei Ji, Min Xu, Chibuike C. Udenigwe, Current Research in Food Science 3(2020) 41-50.

9.     Shola Elijah Adeniji, Gideon Adamu Shallangwa, David Ebuka Arthur, Mustapha Abdullahi, A. Y. Mahmoud, Abdurrashid Haruna, Heliyon 6(2020) e03639.

10.  Nasser Abdulatif Al- Shabib, Javed Masood Khan, Ajamaluddin Malik, MD Tabish Rehman, Mohamed F. ALAjimi, Fohad Mabood Husain, Aqeel Ahmad, Priyankar Sen, Journal of King Said University- Science 32(2020) 2034- 2040.

11.  Jain Wang, Zhaokun Wang, Junyuan Zhang, Baichun Hu, Jia Yu, Xingjie Guo, Journal of the Taiwan Institute of Chemical Engineers 95(2019) 635-642.

12.  Deepu Mathew, Lidiya John P., Manila T. M, Divyasree P., Sandhya Rajan V.T.K. Food Science and Human Wellness 6 (2017) 202- 216.

13.  Asif Hussain, Shah Alam Khan, S. monawwar Imam, Aftab Ahmad, Syed Hussain Basha, Journal of Saudi Chemical Society (2018) 22, 469- 484.

14.  Maryam A. Jordaan, Oluwakemi Ebenezer, Nkulueko Damoyi, Michael Shapi, Heliyon 6(2020) e04642.

15.  Assia Belhassan, Hanane Zaki, Mohamed Benlyas, Tahar Lakhifi, Mohammed Bouchirne, Heliyon 5(2019) e02446.,

16.  Mohammad K. Parvez, Md. Tabish Rehman, Perwez Alam, Mohammed S, Al- Dosari, Saleh I. Alqasoumi, Mohammed F. Alajimi, Saudi Pharmaceutical Journal 27(2019) 389-400.

17.  Hanine Hadni, Menana Elhallaoui, Heliyon 5 (2019) e02357.

18.  Aliyu Wappah Mahmud, Gideon Adamu Shallangwa, Adamu Uzairu, Heliyon 6(2020) e03449.

19.  K. Jayasheela, P.B. Nagabalasubramanian, S. Periandy, Heliyon 6(2020) e04775.

20.  Shola Elijah Adeniji, Sani Uba, Adamu Uzairu, Future Journal of Pharmaceutical Science 4 (2018) 284-295.

21.  Shola Elijah Adeniji, Sani Uba, Adamu Uzairu, Journal of Saud University- Science 32 (2020) ,475- 485.

22.  Ana-Maria Udrea, Speranta Avram, Simona Nistorescu, Mihail-Lucian Pascu, Mihail - Lucian Pascu, Mihaela Oana Romanitan, journal of photochemistry and photobiology, B: Biology 211(2020)111997.

 

 

 

Received on 07.11.2020                    Modified on 23.11.2020

Accepted on 14.12.2020                   ©AJRC All right reserved

Asian J. Research Chem. 2021; 14(2):135-138.

DOI: 10.5958/0974-4150.2021.00025.0